Jonathan Melquist, MD Office and Other Patient Information
Primary Office
Office 1: Baptist MD Anderson Cancer Center
, Jacksonville, FL 32207
904.202.2754
Jonathan Melquist, MD Biography and Info
Jonathan Melquist, MD, has extensive training in surgical and clinical management of a wide spectrum of urologic problems. He applies his education and research from MD Anderson Cancer Center in Houston to provide advanced care for bladder, kidney, prostate, testicular, and adrenal cancers, and has broad experience in treating general urologic conditions. His areas of expertise include:
- Adrenal Masses
- Bladder Cancer
- Kidney Cancer
- Penile and Prostate Cancer
- Testicular Cancer
- Hematuria
- Elevated PSA
About Me
I am a native Midwesterner who quickly fell in love with North Florida. Prior to relocating to Jacksonville, I spent my initial career as a clinical associate in Tallahassee and as a clinical assistant professor at Florida State University. My wife and I and our four kids enjoy biking and sail kayaking and other outdoor adventures that the area has to offer.
There is no greater honor than guiding a patient through the often-complex realm of medicine. With each passing day, our wealth of knowledge of the human body and its ailments expands. Charting the best management course for a patient can be challenging, and my goal as the physician is to advise and advocate for them.
Titles
- Chief, Section of Urologic Oncology
Specialties
- Urological Oncology
- Urology
Boards
- American Board of Urology (Urology)
Languages
- English
Hospital Affiliation
- Baptist Medical Center Jacksonville
- Baptist Medical Center South
Legal Practice Name
- Baptist MD Anderson Cancer Physicians, Inc.
Jonathan Melquist, MD Additional Information
Education & Training
-
Bachelor of Science - Undergraduate
Purdue University - West Lafayette , IN
1998 – 2002
-
Doctor of Medicine - Medical School
University of Minnesota - Minneapolis , MN
2002 – 2007
-
Doctor of Medicine - Residency
State Univeristy of New York - Syracuse , NY
2012 – 2013
-
Doctor of Medicine - Fellowship
University of Texas MD Anderson Cancer Center - Houston , TX
2013 – 2015
Publications
-
The importance of clinical stage among patients with a complete pathologic response at radical cystectomy after neoadjuvant chemotherapy. PMID: 26943643
Parker WP, Ho PL, Boorjian SA, Melquist JJ, Thapa P, Holzbeierlein JM, Frank I, Kamat AM, Lee EK
World J Urol 2016 Nov. 34(11)1561-1566. Epub 2016 Mar 4.
PMID: 26943643 [PubMed - indexed for MEDLINE]
-
Comparison of Single-docking Robotic-assisted and Traditional Laparoscopy for Retroperitoneal Lymph Node Dissection During Nephroureterectomy With Bladder Cuff Excision for Upper-tract Urothelial Carcinoma. PMID: 26494291
Melquist JJ, Redrow G, Delacroix S, Park A, Faria EE, Karam JA, Matin SF
Urology 2016 Jan. 87216-23 doi: 10.1016/j.urology.2015.07.070. Epub 2015 Oct 19.
PMID: 26494291 [PubMed - indexed for MEDLINE]
-
Outcome of patients with clinically node-positive bladder cancer undergoing consolidative surgery after preoperative chemotherapy: The M.D. Anderson Cancer Center Experience. PMID: 26421586
Ho PL, Willis DL, Patil J, Xiao L, Williams SB, Melquist JJ, Tart K, Parikh S, Shah JB, Delacroix SE, Navai N, Siefker-Radtke A, Dinney CP, Pisters LL, Kamat AM
Urol Oncol 2016 Feb. 34(2)59.e1-8 doi: 10.1016/j.urolonc.2015.08.012. Epub 2015 Oct 1.
PMID: 26421586 [PubMed - indexed for MEDLINE]
-
The effect of concomitant carcinoma in situ on neoadjuvant chemotherapy for urothelial cell carcinoma of the bladder: inferior pathological outcomes but no effect on survival. PMID: 25451834
Parker WP, Ho PL, Melquist JJ, Scott K, Holzbeierlein JM, Lopez-Corona E, Kamat AM, Lee EK
J Urol 2015 May. 193(5)1494-9 doi: 10.1016/j.juro.2014.11.003. Epub 2014 Nov 11.
PMID: 25451834 [PubMed - indexed for MEDLINE]
-
Alemtuzumab with corticosteroid minimization for pediatric deceased donor renal transplantation: a seven-yr experience. PMID: 24712738
Supe-Markovina K, Melquist JJ, Connolly D, DiCarlo HN, Waltzer WC, Fine RN, Darras FS
Pediatr Transplant 2014 Jun. 18(4)363-8 doi: 10.1111/petr.12253. Epub 2014 Apr 9.
PMID: 24712738 [PubMed - indexed for MEDLINE]
-
Conditionally replicating adenovirus-mediated gene therapy in bladder cancer: an orthotopic in vivo model. PMID: 16818192
Melquist JJ, Kacka M, Li Y, Malaeb BS, Elmore J, Baseman AG, Hsieh JT, Koeneman KS
Urol Oncol 2006 Jul-Aug. 24(4)362-71.
PMID: 16818192 [PubMed - indexed for MEDLINE]
Additional Publications from Jonathan Melquist, MD (6 Citations)